Securing Your Manufacturing Capacity During the Pandemic

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
In this presentation, Richard Lee, Head of DP at Samsung Biologics, talks about the importance of securing secondary source to your pharmaceutical supply chain in a post-Corona era, and how Samsung Biologics is successfully coping with the global pandemic to ensure safety of our employees as well as our client campaigns.

Speaker - Richard Lee, Head of Drug Product Business Unit, Samsung Biologics
Sponsored By